Walker-Warburg Syndrome
Symptoms, Doctors, Treatments, Advances & More

Walker-Warburg Syndrome Overview

Save information for later
Sign Up

Learn About Walker-Warburg Syndrome

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Walker-Warburg Syndrome Local Doctors?
Elite in Walker-Warburg Syndrome
Elite in Walker-Warburg Syndrome
Tokyo, JP 

Tatsushi Toda practices practicing medicine in Tokyo, Japan. Toda is rated as an Elite expert by MediFind in the treatment of Walker-Warburg Syndrome. They are also highly rated in 54 other conditions, according to our data. Their clinical expertise encompasses Walker-Warburg Syndrome, Fukuyama Type Muscular Dystrophy, Lissencephaly, Thrombectomy, and Bone Marrow Transplant.

Elite in Walker-Warburg Syndrome
Elite in Walker-Warburg Syndrome
Nankoku, JP 

Mariko Ikeda-Taniguchi practices practicing medicine in Nankoku, Japan. Ms. Ikeda-Taniguchi is rated as an Elite expert by MediFind in the treatment of Walker-Warburg Syndrome. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Walker-Warburg Syndrome, Fukuyama Type Muscular Dystrophy, Lissencephaly, and X-Linked Retinal Dysplasia.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Walker-Warburg Syndrome
Elite in Walker-Warburg Syndrome
Toyoake, JP 

Kazuhiro Kobayashi practices practicing medicine in Toyoake, Japan. Mr. Kobayashi is rated as an Elite expert by MediFind in the treatment of Walker-Warburg Syndrome. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Walker-Warburg Syndrome, Fukuyama Type Muscular Dystrophy, Lissencephaly, Hydrocephalus Skeletal Anomalies, and Laryngectomy.

What are the latest Walker-Warburg Syndrome Clinical Trials?
Long-Term Development of Muscular Dystrophy Outcome Assessments (GRASP-01-005)

Summary: This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset Pompe disease (LOPD).

Match to trials
Find the right clinical trials for you in under a minute
Get started
Congenital Muscle Disease Patient and Proxy Reported Outcome Study

Summary: The Congenital Muscle Disease Patient and Proxy Reported Outcome Study (CMDPROS) is a longitudinal 10 year study to identify and trend care parameters, adverse events in the congenital muscle diseases using the Congenital Muscle Disease International Registry (CMDIR) to acquire necessary data for adverse event calculations (intake survey and medical records curation). To support this study and bec...